Canadian Markets closed

Opexa Therapeutics, Inc. (OPXA)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.90-0.02 (-1.64%)
At close: 3:59PM EDT
People also watch
Full screen
Previous Close0.92
Bid0.86 x 4000
Ask0.96 x 2000
Day's Range0.89 - 0.92
52 Week Range0.50 - 4.93
Avg. Volume445,298
Market Cap6.89M
PE Ratio (TTM)-0.96
EPS (TTM)-0.94
Earnings DateNov 11, 2016 - Nov 14, 2016
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.00
Trade prices are not sourced from all markets
  • American City Business Journals6 days ago

    ​Cambridge rare disease startup Acer to go public through merger

    Acer Therapeutics, a three-year-old Cambridge biotech developing drugs for ultra-rare diseases, said Monday that it will go public through a reverse merger with a small Texas company. Acer said it would merge with Opexa Therapeutics (OPXA), which laid off all but two of its 20 employees after its lead drug for multiple sclerosis flunked a mid-stage trial in October. In connection with the deal, Acer said it would receive a $15.7 million round of financing led by TVM Capital, a life sciences venture firm based in Germany.

  • Zacks18 days ago

    Company News for July 05, 2017

    Companies in the News are: RATE,EQT,MSDI,OPXA

  • TheStreet.com20 days ago

    Opexa Shares Jump on Merger with Acer Therapeutics

    After consummation Opexa's name will be changed to Acer Therapeutics Inc.